Welcome to our dedicated page for PRGMX news (Ticker: PRGMX), a resource for investors and traders seeking the latest updates and insights on PRGMX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PRGMX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PRGMX's position in the market.
T. Rowe Price (TROW) launched the T. Rowe Price Securitized Income ETF (TSCZ), a fully transparent, actively managed fixed income ETF that began trading on NYSE Arca on September 3, 2026.
TSCZ seeks high current income by investing across U.S. securitized credit sectors, including ABS, CMBS, CLOs, and non-agency RMBS, and has a total expense ratio of 0.20%. The fund is co-managed by Jean-Marc Breaux and Ramon de Castro, who bring 20 and over 30 years of investment experience, respectively. With this launch, T. Rowe Price's ETF lineup grows to 35 funds across fixed income, equities, multi-asset, digital assets, and thematic strategies. Separately, the firm has agreed to acquire F/m Investments, which at expected closing in early 2027 is anticipated to increase fixed income assets under management by nearly 9% and more than double its fixed income ETF assets under management.